Abbvie Inc at Leerink Global Healthcare Conference Transcript

Feb 25, 2020 / 03:30PM GMT
Geoffrey Craig Porges - SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst

Okay. We're going to get started in a few minutes -- in a few seconds, let me modify that, with our next company. Terrific. All right. Ready to get underway. So welcome to this session. I'm Geoff Porges, Director of Therapeutics Research. I'm delighted to welcome AbbVie to our conference today. AbbVie is represented by Mike Severino who's President, and I believe still Head of R&D as well; and Rob Michael, who's Executive Vice President and Chief Financial Officer. Gentlemen, thank you for joining us at our Global Healthcare Conference.

Questions and Answers:

Geoffrey Craig Porges - SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst

So there's all sorts of things we could talk about, Mike, but maybe we could talk about the -- first of all, the new indication pipeline for your recently introduced medicines and some that are late stages. But could you talk about
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot